-
Founded in:
1998-10-30 -
Country:
China -
Address:
No. 6 Xinluo Street, Hunnan New District, Shenyang -
Tax NO.:
912101121178724277 -
Registered Funds:
100 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Glycerol |
It can lubricate and stimulate the intestinal wall, soften the stool and make it easier to pass.
More
It can lubricate and stimulate the intestinal wall, soften the stool and make it easier to pass. |
52.8-58.3%(weight/weight) | 56-81-5 | 61 |
| Water |
This product can lubricate and stimulate the intestinal wall, soften the stool and make it easier to excrete.
More
This product can lubricate and stimulate the intestinal wall, soften the stool and make it easier to excrete. |
7732-18-5 | 11 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Indometacin |
For external use, apply an appropriate amount of this product to the affected area and rub gently, 2 to 3 times a day.
More
For external use, apply an appropriate amount of this product to the affected area and rub gently, 2 to 3 times a day. |
53-86-1 | 23 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Dipyridamole |
It has anti-thrombotic effects. Dipyridamole inhibits platelet aggregation, and high concentrations (50 μg/ml) can inhibit platelet release. The mechanism of action may be: (1) Inhibits adenosine uptake by platelets, epithelial cells, and erythrocytes. At therapeutic concentrations, the inhibitory effect is dose-dependent. The local adenosine concentration increases, acting on the A2 receptor of platelets, stimulating adenylate cyclase, increasing cyclic adenosine monophosphate (cAMP) in platelets, thereby inhibiting platelet aggregation; (2) Inhibits phosphodiesterase (PDE) in various tissues. Therapeutic concentrations inhibit cyclic guanosine monophosphate phosphodiesterase (cGMP-PDE), and enhance the increase in cGMP concentration caused by endothelial relaxing factor (EDRF); (3) Inhibits the formation of thromboxane A2 (TXA2), which is a strong agonist of platelet activity; (4) Enhances the effect of endogenous PGI2. Dipyridamole has a vasodilatory effect.
More
It has anti-thrombotic effects. Dipyridamole inhibits platelet aggregation, and high concentrations (50 μg/ml) can inhibit platelet release. The mechanism of action may be: (1) Inhibits adenosine uptake by platelets, epithelial cells, and erythrocytes. At therapeutic concentrations, the inhibitory effect is dose-dependent. The local adenosine concentration increases, acting on the A2 receptor of platelets, stimulating adenylate cyclase, increasing cyclic adenosine monophosphate (cAMP) in platelets, thereby inhibiting platelet aggregation; (2) Inhibits phosphodiesterase (PDE) in various tissues. Therapeutic concentrations inhibit cyclic guanosine monophosphate phosphodiesterase (cGMP-PDE), and enhance the increase in cGMP concentration caused by endothelial relaxing factor (EDRF); (3) Inhibits the formation of thromboxane A2 (TXA2), which is a strong agonist of platelet activity; (4) Enhances the effect of endogenous PGI2. Dipyridamole has a vasodilatory effect. |
58-32-2 | 36 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Metronidazole |
It has a strong antibacterial effect on most anaerobic bacteria. Its bactericidal mechanism has not been fully elucidated. The nitroreductase of anaerobic bacteria plays an important role in the energy metabolism of sensitive strains. The nitro group of this product is reduced to a cytotoxin, which acts on the DNA metabolism process of the cell and promotes the death of bacteria.
More
It has a strong antibacterial effect on most anaerobic bacteria. Its bactericidal mechanism has not been fully elucidated. The nitroreductase of anaerobic bacteria plays an important role in the energy metabolism of sensitive strains. The nitro group of this product is reduced to a cytotoxin, which acts on the DNA metabolism process of the cell and promotes the death of bacteria. |
0.2g | 443-48-1 | 39 |
| Atificial Cow-bezoar |
Antipyretic and anti-inflammatory effects
More
Antipyretic and anti-inflammatory effects |
5mg | 1002-00-2 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ethambutol dihydrochloride |
This product is a synthetic antibacterial anti-tuberculosis drug. It has strong activity against bacteria in the growth and reproduction stage, but almost no effect on bacteria in the dormant stage. It has high antibacterial activity against various types of mycobacteria. Mycobacterium tuberculosis has no cross-resistance to this product and other drugs. It may inhibit the metabolism of sensitive bacteria, inhibit RNA synthesis, and interfere with the protein metabolism of Mycobacterium tuberculosis, thereby leading to bacterial death.
More
This product is a synthetic antibacterial anti-tuberculosis drug. It has strong activity against bacteria in the growth and reproduction stage, but almost no effect on bacteria in the dormant stage. It has high antibacterial activity against various types of mycobacteria. Mycobacterium tuberculosis has no cross-resistance to this product and other drugs. It may inhibit the metabolism of sensitive bacteria, inhibit RNA synthesis, and interfere with the protein metabolism of Mycobacterium tuberculosis, thereby leading to bacterial death. |
1070-11-7 | 13 |